Clinical Trial Update: Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety for primary hypercholesterolemia; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: UNKNOWN